Efficacy and safety of Bruton's tyrosine kinase inhibitors in relapsed / refractory mantle cell lymphoma patients: a meta-analysis

doi:10.3969/j.issn.1672-3384.2024.07.013

Xiao ZHANG, Yanan WEI, Ye KANG, Jie ZHOU, Hao LIU, Yanshuai WANG, Chunjuan ZHOU

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (7) : 69-75.

PDF(1354 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (7) : 69-75. DOI: 10.3969/j.issn.1672-3384.2024.07.013

Original Article

Efficacy and safety of Bruton's tyrosine kinase inhibitors in relapsed / refractory mantle cell lymphoma patients: a meta-analysis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(7): 69-75 https://doi.org/10.3969/j.issn.1672-3384.2024.07.013

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1354 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-11-23	2024-07-20
Issue Date
2024-08-08

Please choose a citation manager

Content to export